← FDA Drug Approvals (Drugs@FDA)

GLIADEL

NDA · New Drug Application · Sponsor: AZURITY · Approved 1996-09-23

Drug application

FDA Application #

NDA020637

Application type

New Drug Application

Brand name

GLIADEL

Generic name

CARMUSTINE

Active ingredients

CARMUSTINE

Dosage form

IMPLANT

Route

INTRACRANIAL

Marketing status

Prescription

Sponsor

AZURITY

Manufacturer

Azurity Pharmaceuticals, Inc.

First approval

1996-09-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown